ADOR Diagnostics Ltd.

About

Funding history · 2 rounds · $22.0M total

Headcount over time

Offices

Q&A

What is ADOR Diagnostics' primary focus?

ADOR Diagnostics develops and manufactures in-vitro multiplex molecular diagnostic solutions for immediate diagnosis of various medical conditions, with a focus on the NATlab system for rapid infectious disease diagnostics.

When was ADOR Diagnostics founded?

ADOR Diagnostics was founded in 2015.

What was ADOR Diagnostics' most recent funding round?

In October 2023, ADOR Diagnostics secured a $7.5 million A Round investment. BATM Advanced Communications Ltd. was a lead investor.

Who are the key executives at ADOR Diagnostics?

Dr. Zvi Marom serves as Chairman, Dr. Eran Zahavy is the CEO, and Dr. Vladimir Hurgin is the VP R&D.

Who is the Chairman of ADOR Diagnostics' Advisory Board?

Nadhim Zahawi was appointed Chairman of the Advisory Board in January 2025.

What is ADOR Diagnostics' total funding raised to date?

ADOR Diagnostics has raised a total of $22 million USD.

What is BATM Advanced Communications Ltd.'s relationship with ADOR Diagnostics?

BATM Advanced Communications Ltd. is a parent company, holding a 43.6% shareholding in ADOR Diagnostics Ltd.

What are the core technologies utilized by ADOR Diagnostics?

ADOR Diagnostics utilizes proprietary molecular biology platforms, including Multiplex Syndromic Panels, Rolling Circle Amplification (RCA), Microfluidics, Isothermal Amplification, and Carbon Array Detection.

Team · 8

Zvi Marom

Founder · Chairman

Eran Zahavy

CEO

Vladimir Hurgin

VP R&D

Nadhim Zahawi

Chairman of Advisory Board

Matthew Fisher

Professor of Fungal Disease Epidemiology, Imperial College London, UK (Advisory Board)

Avigdor Shafferman

CEO (Ret.) Israel Institute of Biological Research (Advisory Board)

Sadik Esener

Director of the Cancer Early Detection Advanced Research center (Advisory Board)

Shevin Jacob

Infectious Diseases Consultant (Advisory Board)

Sectors & technology